Sarepta Therapeutics, Inc. - Common Stock (NQ:SRPT)
19.01
+0.17
(+0.90%)
Streaming Delayed Price
Updated: 11:42 AM EST, Feb 25, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 466,275 |
| Open | 18.86 |
| Bid (Size) | 18.99 (100) |
| Ask (Size) | 19.02 (300) |
| Prev. Close | 18.84 |
| Today's Range | 18.75 - 19.17 |
| 52wk Range | 10.41 - 109.55 |
| Shares Outstanding | 93,148,652 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Why Did SRPT Stock Rise 6% In Pre-Market Today? ↗
January 26, 2026
Which stocks are moving after the closing bell on Friday? ↗
January 23, 2026
2 Beaten-Down Stocks That Could Sink Even More in 2026 ↗
January 21, 2026
Why Is SRPT Stock Falling Today? ↗
December 11, 2025
Frequently Asked Questions
Is Sarepta Therapeutics, Inc. - Common Stock publicly traded?
Yes, Sarepta Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Sarepta Therapeutics, Inc. - Common Stock trade on?
Sarepta Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Sarepta Therapeutics, Inc. - Common Stock?
The ticker symbol for Sarepta Therapeutics, Inc. - Common Stock is SRPT on the Nasdaq Stock Market
What is the current price of Sarepta Therapeutics, Inc. - Common Stock?
The current price of Sarepta Therapeutics, Inc. - Common Stock is 19.01
When was Sarepta Therapeutics, Inc. - Common Stock last traded?
The last trade of Sarepta Therapeutics, Inc. - Common Stock was at 02/25/26 11:42 AM ET
What is the market capitalization of Sarepta Therapeutics, Inc. - Common Stock?
The market capitalization of Sarepta Therapeutics, Inc. - Common Stock is 1.77B
How many shares of Sarepta Therapeutics, Inc. - Common Stock are outstanding?
Sarepta Therapeutics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.